Generex Biotechnology Corporation (GNBT) Touts Pipeline Potential of Antigen Express, Inc. (GNBT) Subsidiary
2/7/2013 10:24:35 AM
More...
|
Generex Biotechnology Corporation (GNBT) Points to Potential of Antigen Express, Inc. (GNBT) Technology Platform Beyond Its AE37 Breast Cancer Vaccine
1/31/2013 9:03:41 AM
More...
|
Generex Biotechnology Corporation (GNBT) Provides an Overview of its Cancer Immunotherapy Product, AE37, and Potential in Early Breast Cancer Given Current and Potential Future Therapies
1/30/2013 9:50:08 AM
More...
|
Generex Biotechnology Corporation (GNBT) Announces Details of Investor Conference Call
1/29/2013 9:53:05 AM
More...
|
Generex Biotechnology Corporation (GNBT) Oral-lyn™ Phase III Dossier Submitted to Indian Government for Marketing Approval
1/23/2013 10:33:36 AM
More...
|
Generex Biotechnology Corporation (GNBT) Announces Investor Conference Call
1/11/2013 9:27:39 AM
More...
|
Generex Biotechnology Corporation (GNBT) Announces $750,000 Capital Investment
12/12/2012 9:10:16 AM
More...
|
Generex Biotechnology Corporation (GNBT) Provides Update on Company Initiatives Including the AE37 Breast Cancer Vaccine Program
11/13/2012 11:13:49 AM
More...
|
Generex Biotechnology Corporation (GNBT) Management Provides Update to Stockholders
9/24/2012 11:41:22 AM
More...
|
Generex Biotechnology Corporation (GNBT) Announces Presentation of Early Results Showing Activity of Cancer Vaccine in Patients with Triple Negative Breast Cancer
9/14/2012 11:13:46 AM
More...
|
|